Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ASCO 2024 | Liquid biopsy to diagnose CNS lymphoma and monitor treatment response

Lakshmi Nayak • 2 Jun 2024
ASCO 2024
Lymphoma

Lakshmi Nayak, MD, Dana-Farber Cancer Institute, Boston, MA, discusses using liquid biopsy to improve diagnosis and monitoring of CNS lymphomas. This research focuses on using cerebrospinal fluid (CSF) or peripheral blood (PB) to detect microscopic disease levels that other methods might miss in order to diagnose disease and monitor treatment response. This interview took place during the 2024 American Society of Clinical Oncology (ASCO) Meeting in Chicago, IL.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

More from Lakshmi Nayak

4:14
A pilot study of axi-cel in primary and secondary CNS lymphomas
Lakshmi Nayak • 2 Jun 2024
5:53
The latest research in primary CNS lymphoma
Lakshmi Nayak • 17 Aug 2021

Related Videos

1:10
The sensitization of immune checkpoint inhibitors with subsequent chemotherapy in R/R HL
Jan Maciej Zaucha • 16 Jun 2024
1:30
The use of targeted drug therapy for aggressive lymphoma
Mariana Bastos • 14 Jun 2024
2:06
Reducing CRS following epcoritamab in R/R FL: insights from an optimization cohort of EPCORE NHL-1
Umberto Vitolo • 15 Jun 2024
1:29
Insights into the uses of ibrutinib for patients with Waldenström’s macroglobulinemia
Ramon Garcia-Sanz • 16 Jun 2024
The content of VJHemOnc is intended for healthcare professionals